Bluebird, Celgene T-Cell Therapy Eliminates Numerous Myeloma With Minimal Side Effects
Two patients with advanced numerous myeloma, a type of blood cancer affecting plasma cells, have been put into stringent accomplish remission ongoing for four and six months, respectively, by a genetically engineered T cell therapy from Bluebird Bio (BLUE) . Contine reading